» Articles » PMID: 39155290

Peripheral Sequestration of Huntingtin Delays Neuronal Death and Depends on N-terminal Ubiquitination

Overview
Journal Commun Biol
Specialty Biology
Date 2024 Aug 18
PMID 39155290
Authors
Affiliations
Soon will be listed here.
Abstract

Huntington's disease (HD) is caused by a glutamine repeat expansion in the protein huntingtin. Mutated huntingtin (mHtt) forms aggregates whose impacts on neuronal survival are still debated. Using weeks-long, continual imaging of cortical neurons, we find that mHtt is gradually sequestrated into peripheral, mainly axonal aggregates, concomitant with dramatic reductions in cytosolic mHtt levels and enhanced neuronal survival. in-situ pulse-chase imaging reveals that aggregates continually gain and lose mHtt, in line with these acting as mHtt sinks at equilibrium with cytosolic pools. Mutating two N-terminal lysines found to be ubiquitinated in HD animal models suppresses peripheral aggregate formation and reductions in cytosolic mHtt, promotes nuclear aggregate formation, stabilizes aggregates and leads to pervasive neuronal death. These findings demonstrate the capacity of aggregates formed at peripheral locations to sequester away cytosolic, presumably toxic mHtt forms and support a crucial role for N-terminal ubiquitination in promoting these processes and delaying neuronal death.

Citing Articles

Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.

Church T, Margolis S Front Cell Dev Biol. 2025; 12:1531797.

PMID: 39990094 PMC: 11842346. DOI: 10.3389/fcell.2024.1531797.

References
1.
Saudou F, Humbert S . The Biology of Huntingtin. Neuron. 2016; 89(5):910-26. DOI: 10.1016/j.neuron.2016.02.003. View

2.
Vitet H, Brandt V, Saudou F . Traffic signaling: new functions of huntingtin and axonal transport in neurological disease. Curr Opin Neurobiol. 2020; 63:122-130. DOI: 10.1016/j.conb.2020.04.001. View

3.
Ghosh R, Tabrizi S . Huntington disease. Handb Clin Neurol. 2018; 147:255-278. DOI: 10.1016/B978-0-444-63233-3.00017-8. View

4.
Rosas H, Salat D, Lee S, Zaleta A, Pappu V, Fischl B . Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain. 2008; 131(Pt 4):1057-68. PMC: 2657201. DOI: 10.1093/brain/awn025. View

5.
Barry J, Bui M, Levine M, Cepeda C . Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway. Neurobiol Dis. 2021; 162:105574. PMC: 9328779. DOI: 10.1016/j.nbd.2021.105574. View